Prescription drug · BLA
NovoLog Mix 70/30 (Insulin aspart) NDC 0169-3685
Insulin aspart 100 [iU]/mL · Injection, Suspension · Subcutaneous · Novo Nordisk Pharmaceutical Industries, LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0169-3685-12 | 0016936851200169368512 | 1 VIAL, GLASS in 1 CARTON (0169-3685-12) / 10 mL in 1 VIAL, GLASSMarketed from Nov 1, 2001 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- NovoLog Mix 70/30
- Generic name (nonproprietary)
- insulin aspart
- Active ingredients
- Insulin aspart — 100 [iU]/mL
- Dosage form
- Injection, Suspension
- Route
- Subcutaneous
- Labeler
- Novo Nordisk Pharmaceutical Industries, LPNDC labeler code 0169
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 021172
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical structure)
- Identifiers
- Product ID 0169-3685_f999a4d9-129e-4cb2-88cb-2a855468882fSPL ID f999a4d9-129e-4cb2-88cb-2a855468882f
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400169368512followed by a unit qualifier and the quantityPackage 00169-3685-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0169-3685
- What is NDC 0169-3685?
- 0169-3685 is the product NDC for NovoLog Mix 70/30 (insulin aspart), Insulin aspart 100 [iU]/mL injection, suspension, listed with the FDA by Novo Nordisk Pharmaceutical Industries, LP. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- NovoLog Mix 70/30 (Insulin aspart).
- What is the active ingredient?
- Insulin aspart.
- Who is the labeler?
- Novo Nordisk Pharmaceutical Industries, LP, NDC labeler code 0169. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for NovoLog Mix 70/30?
- 5 other product NDCs are listed under this name. See all NovoLog Mix 70/30 NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other NovoLog Mix 70/30 products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | REMEDYREPACK INC. | 70518-2119 | 70518-2119-00 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2201 | 00169-2201-25 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3696 | 00169-3696-19 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-2272 | 50090-2272-00 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2200 | 00169-2200-11 |
Other NDCs under BLA 021172
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| .Insulin Aspart Protamine and Insulin Aspartinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-4959 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | REMEDYREPACK INC. | 70518-3236 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-200 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-203 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2200 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2201 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3696 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-2272 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | REMEDYREPACK INC. | 70518-2119 |